Pancreatic Function Tests — MCQs
A 25-year-old obese woman who denies any history of alcohol abuse presents with severe abdominal pain radiating to the back. Laboratory results indicate an increase in serum amylase and lipase, with a marked decrease in calcium. Which of the following likely has caused this condition?
Exocrine pancreatic insufficiency is seen in:
A 45-year-old patient with chronic pancreatitis is suffering from malnutrition and weight loss secondary to inadequate pancreatic exocrine secretions. Which of the following is true regarding pancreatic secretions?
Enteropeptidase enzyme is secreted by:
A 50-year-old chronic alcoholic presents to the emergency room with 12 hours of severe abdominal pain. The pain radiates to the back and is associated with an urge to vomit. Physical examination discloses exquisite abdominal tenderness. Laboratory studies show elevated serum amylase. Which of the following morphologic changes would be expected in the peripancreatic tissue of this patient?
A patient presents with jaundice, dark urine, and high unconjugated bilirubin. Most likely cause?
Hyperglycemia occurs after what % of beta cell mass is destroyed:
Which of the following conditions masks low serum haptoglobin in hemolysis?
Which of the following vitamin deficiencies is found in patients with gastric cancer?
In carcinoma prostate with metastasis, which of the following biochemical markers is typically elevated?
Pancreatic Function Tests Indian Medical PG Practice Questions and MCQs
Question 1: A 25-year-old obese woman who denies any history of alcohol abuse presents with severe abdominal pain radiating to the back. Laboratory results indicate an increase in serum amylase and lipase, with a marked decrease in calcium. Which of the following likely has caused this condition?
- A. Abetalipoproteinemia
- B. Cholelithiasis (Correct Answer)
- C. Cystic fibrosis
- D. Alcohol
Explanation: **Cholelithiasis** - **Obesity** is a significant risk factor for gallstone formation [2], which can obstruct the pancreatic duct and lead to **pancreatitis** [1]. - The classic presentation of severe abdominal pain radiating to the back, elevated **amylase** and **lipase**, and **hypocalcemia** (due to fat saponification in severe pancreatitis) is highly consistent with pancreatitis secondary to gallstones [1]. *Abetalipoproteinemia* - This is a rare genetic disorder characterized by the inability to synthesize apolipoprotein B, leading to severe **malabsorption** and **neurological deficits**, not pancreatitis. - While it involves lipid abnormalities, it typically presents with steatorrhea, growth failure, and ataxia, not acute abdominal pain. *Cystic fibrosis* - Individuals with **cystic fibrosis** can develop pancreatic insufficiency and chronic pancreatitis due to thick secretions blocking pancreatic ducts, but **acute severe pancreatitis with hypocalcemia** is less typical as an initial presentation in a 25-year-old without a prior diagnosis. - Features like **recurrent respiratory infections** and **failure to thrive** would usually precede or accompany pancreatic issues. *Alcohol* - Although **alcohol abuse** is a very common cause of pancreatitis, the patient explicitly **denies any history of alcohol abuse**, making this etiology less likely in this specific case. - Clinically, alcohol-induced pancreatitis presents similarly, but the absence of positive history rules it out as the primary cause.
Question 2: Exocrine pancreatic insufficiency is seen in:
- A. Shwachman-Diamond syndrome (Correct Answer)
- B. Rubinstein-Taybi syndrome
- C. Seckel syndrome
- D. Diamond-Blackfan syndrome
Explanation: ***Shwachman-Diamond syndrome*** - This syndrome is characterized by **exocrine pancreatic insufficiency**, neutropenia, skeletal abnormalities, and growth retardation. - The pancreatic insufficiency leads to **malabsorption** and **steatorrhea** due to insufficient production of digestive enzymes. *Rubinstein-Taybi syndrome* - This syndrome is characterized by broad thumbs and great toes, intellectual disability, and distinctive facial features, but not primarily by exocrine pancreatic insufficiency. - It is caused by mutations in the **CREBBP** or **EP300** genes, which are not directly involved in pancreatic function. *Seckel syndrome* - This is a rare genetic disorder characterized by **primordial dwarfism**, microcephaly, and intellectual disability. - While it affects growth and development, it is not typically associated with exocrine pancreatic insufficiency. *Diamond-Blackfan syndrome* - This syndrome primarily involves **pure red cell aplasia**, leading to severe anemia. - Although it can have various congenital anomalies, **exocrine pancreatic insufficiency** is not a characteristic feature of this condition.
Question 3: A 45-year-old patient with chronic pancreatitis is suffering from malnutrition and weight loss secondary to inadequate pancreatic exocrine secretions. Which of the following is true regarding pancreatic secretions?
- A. Secretin releases fluid rich in enzymes.
- B. Secretin releases fluid rich mainly in electrolytes and bicarbonate. (Correct Answer)
- C. Cholecystokinin releases fluid, predominantly rich in electrolytes, and bicarbonate.
- D. All pancreatic enzymes are secreted in an inactive form.
Explanation: ***Secretin releases fluid rich mainly in electrolytes and bicarbonate.*** - **Secretin** is stimulated by an acidic pH in the duodenum and primarily promotes the secretion of **bicarbonate-rich fluid** from the pancreas, which neutralizes gastric acid. - This bicarbonate-rich fluid helps create an optimal pH environment for digestive enzymes in the small intestine. *All pancreatic enzymes are secreted in an inactive form.* - While many pancreatic enzymes, particularly proteases like **trypsinogen** and **chymotrypsinogen**, are indeed secreted as inactive zymogens to prevent auto-digestion of the pancreas. - Some enzymes, such as **lipase** and **amylase**, are secreted in their active forms. *Secretin releases fluid rich in enzymes.* - Secretin primarily stimulates the release of **bicarbonate-rich fluid** to neutralize acidic chyme. - Enzyme rich secretions are primarily stimulated by **cholecystokinin (CCK)**. *Cholecystokinin releases fluid, predominantly rich in electrolytes, and bicarbonate.* - **Cholecystokinin (CCK)** mainly stimulates the secretion of **enzyme-rich pancreatic fluid** and contraction of the gallbladder. - The release of fluid rich in electrolytes and bicarbonate is primarily regulated by **secretin**.
Question 4: Enteropeptidase enzyme is secreted by:
- A. Ileum
- B. Duodenum (Correct Answer)
- C. Stomach
- D. Jejunum
Explanation: ***Duodenum*** - **Enteropeptidase** (also known as enterokinase) is a key enzyme primarily secreted by the mucosal cells of the **duodenum**. - Its main function is to activate **trypsinogen** (from the pancreas) into **trypsin**, initiating a cascade of protein digestion. *Ileum* - The ileum is primarily involved in the absorption of **vitamin B12** and **bile salts**. - It does not significantly contribute to the secretion of digestive enzymes like enteropeptidase. *Stomach* - The stomach secretes **pepsin** (to digest proteins) and **hydrochloric acid**, and is involved in initial protein digestion. - It does not produce enteropeptidase, which acts much later in the digestive process. *Jejunum* - The jejunum is a major site for the absorption of **nutrients** like carbohydrates, fats, and proteins. - While it has some brush border enzymes, the primary secretion of enteropeptidase occurs in the duodenum.
Question 5: A 50-year-old chronic alcoholic presents to the emergency room with 12 hours of severe abdominal pain. The pain radiates to the back and is associated with an urge to vomit. Physical examination discloses exquisite abdominal tenderness. Laboratory studies show elevated serum amylase. Which of the following morphologic changes would be expected in the peripancreatic tissue of this patient?
- A. Caseous necrosis
- B. Fibrinoid necrosis
- C. Fat necrosis (Correct Answer)
- D. Coagulative necrosis
Explanation: ***Fat necrosis*** - The patient's presentation with **severe abdominal pain radiating to the back**, **elevated serum amylase**, and **history of chronic alcoholism** is highly suggestive of **acute pancreatitis** [2], [3]. - **Fat necrosis** is a characteristic morphologic change in **acute pancreatitis**, occurring when activated pancreatic enzymes (especially **lipases**) leak into the peripancreatic tissue and break down fat, leading to the formation of **calcium soaps** [1]. *Caseous necrosis* - This type of necrosis is typically associated with **granulomatous inflammation**, most commonly seen in **tuberculosis** [1]. - It results in a **cheese-like appearance** and is not characteristic of pancreatic injury from acute pancreatitis [1]. *Fibrinoid necrosis* - **Fibrinoid necrosis** involves damage to **blood vessel walls**, where plasma proteins (including fibrin) leak into the vessel wall, appearing amorphous and eosinophilic. - It is typically seen in **immunologic diseases** (e.g., vasculitis) or severe hypertension, not acute pancreatitis. *Coagulative necrosis* - This type of necrosis is classically caused by **ischemia** (e.g., myocardial infarction, renal infarction), where cell outlines are preserved for a period due to the denaturation of structural proteins and enzymes. - While ischemia can lead to pancreatic damage, the primary and distinctive form of necrosis in peripancreatic fat during acute pancreatitis is **fat necrosis**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 55. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 406-407. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 889-890.
Question 6: A patient presents with jaundice, dark urine, and high unconjugated bilirubin. Most likely cause?
- A. Hemolysis (Correct Answer)
- B. Cholestasis
- C. Hepatitis
- D. Pancreatic cancer
Explanation: ***Hemolysis*** - **Hemolysis** leads to an increased breakdown of red blood cells, overwhelming the liver's capacity to conjugate bilirubin [1]. - This results in a buildup of **unconjugated bilirubin**, causing **jaundice** and **dark urine** due to increased urobilinogen [1]. *Cholestasis* - **Cholestasis** involves impaired bile flow, leading to an accumulation of **conjugated bilirubin** in the blood, not unconjugated [1]. - It typically causes pale stools and dark urine due to conjugated bilirubinuria, but the primary bilirubin type is different [1]. *Hepatitis* - **Hepatitis** causes inflammation of the liver, impairing both uptake and conjugation of bilirubin, leading to elevated levels of both **conjugated and unconjugated bilirubin** [2]. - While it can cause jaundice and dark urine, a predominant rise in **unconjugated bilirubin** alone is less characteristic [2]. *Pancreatic cancer* - **Pancreatic cancer**, especially of the head of the pancreas, can cause **obstructive jaundice** by compressing the common bile duct [1]. - This results in an accumulation of **conjugated bilirubin** due to impaired bile flow, rather than an increase in unconjugated bilirubin [1].
Question 7: Hyperglycemia occurs after what % of beta cell mass is destroyed:
- A. 40%
- B. 80% (Correct Answer)
- C. 60%
- D. 20%
Explanation: ***80%*** - **Hyperglycemia** typically manifests only after a significant portion of **beta cell mass** (around 80-90%) has been destroyed. - This extensive loss of **insulin-producing cells** compromises the body's ability to maintain normal glucose levels [1]. *20%* - A 20% destruction of beta cell mass is generally **insufficient** to cause clinical hyperglycemia. - The remaining beta cells can usually compensate for this relatively small loss through increased insulin secretion. *40%* - While 40% loss represents a considerable reduction, it's often still within the compensatory capacity of the pancreas. - At this stage, individuals might experience **impaired glucose tolerance** but not overt hyperglycemia [1]. *60%* - Even with a 60% loss, the body may still be able to maintain near-normal glucose levels, especially in the early stages of beta cell destruction [1]. - Hyperglycemia is more likely to develop as the destruction progresses beyond this point.
Question 8: Which of the following conditions masks low serum haptoglobin in hemolysis?
- A. Bile duct obstruction (Correct Answer)
- B. Liver disease
- C. Malnutrition
- D. Pregnancy
Explanation: **Explanation:** The primary clinical utility of **Haptoglobin** is as a marker for **intravascular hemolysis**. Haptoglobin is an acute-phase reactant synthesized by the liver that binds free hemoglobin. During hemolysis, haptoglobin levels drop significantly as it is cleared by the reticuloendothelial system. **Why Bile Duct Obstruction is correct:** Haptoglobin is a **positive acute-phase reactant**. In conditions like **bile duct obstruction (obstructive jaundice)**, inflammation or biliary stasis triggers an increase in the hepatic synthesis of haptoglobin. This elevation can artificially "mask" or normalize the low levels typically seen in hemolysis, leading to a false-negative result for hemolytic anemia. **Analysis of Incorrect Options:** * **Liver Disease:** Since haptoglobin is synthesized in the liver, severe liver disease (e.g., cirrhosis) leads to **decreased** production. This would mimic or exacerbate low levels rather than masking them. * **Malnutrition:** Protein-energy malnutrition leads to a generalized decrease in plasma protein synthesis, including haptoglobin, resulting in **low** levels. * **Pregnancy:** Pregnancy is associated with a physiological decrease in haptoglobin levels (estrogen effect), which would not mask a hemolytic state. **NEET-PG High-Yield Pearls:** * **Gold Standard for Hemolysis:** A **decreased** serum haptoglobin level is one of the most sensitive markers for confirming hemolysis. * **Acute Phase Reactants:** Remember that haptoglobin levels rise in infection, trauma, and malignancy, which can confound the diagnosis of co-existing hemolysis. * **Neonate Fact:** Haptoglobin levels are naturally very low or absent in newborns (physiologic ahaptoglobinemia) and reach adult levels by 6 months of age.
Question 9: Which of the following vitamin deficiencies is found in patients with gastric cancer?
- A. Vitamin C
- B. Vitamin B12 (Correct Answer)
- C. Vitamin A
- D. Vitamin D
Explanation: **Explanation:** The correct answer is **Vitamin B12**. **Why Vitamin B12 is the correct answer:** Gastric cancer often involves the destruction or surgical resection of the gastric mucosa, specifically the **parietal cells** located in the body and fundus of the stomach. These cells are responsible for secreting **Intrinsic Factor (IF)**. Vitamin B12 (cobalamin) requires IF to form a complex that survives the acidic environment of the stomach and allows for absorption in the **terminal ileum**. In gastric cancer, the loss of parietal cells leads to IF deficiency, resulting in secondary Vitamin B12 malabsorption and potentially megaloblastic anemia (pernicious-like state). Additionally, the achlorhydria (lack of HCl) associated with gastric atrophy prevents the release of B12 from dietary proteins. **Why the other options are incorrect:** * **Vitamin C:** While low levels are associated with an increased *risk* of developing gastric cancer due to reduced antioxidant protection, the cancer itself does not characteristically cause a deficiency through a specific physiological mechanism like B12. * **Vitamin A & D:** These are fat-soluble vitamins. Their deficiency is typically associated with fat malabsorption syndromes (e.g., pancreatic insufficiency, biliary obstruction, or celiac disease) rather than the specific loss of gastric intrinsic factor. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Absorption:** Vitamin B12 is absorbed in the **terminal ileum**, while Iron is absorbed in the **duodenum**. * **Post-Gastrectomy:** Patients undergoing total gastrectomy for gastric cancer *must* receive lifelong parenteral Vitamin B12 supplementation. * **Schilling Test:** Historically used to differentiate between causes of B12 deficiency (though largely replaced by antibody testing and metabolite levels). * **Associated Finding:** Look for **hypersegmented neutrophils** on a peripheral smear in patients with B12 deficiency.
Question 10: In carcinoma prostate with metastasis, which of the following biochemical markers is typically elevated?
- A. Erythrocyte Sedimentation Rate (ESR)
- B. Alkaline Phosphatase (Correct Answer)
- C. Acid Phosphatase
- D. Bilirubin
Explanation: **Explanation:** The correct answer is **Alkaline Phosphatase (ALP)**. In the context of prostate carcinoma, elevation of ALP is a hallmark of **osteoblastic (bone-forming) metastasis**. When prostate cancer cells spread to the bone, they stimulate osteoblasts to lay down new mineralized bone. ALP is a byproduct of osteoblastic activity; hence, its serum levels rise significantly as a marker of bone remodeling and turnover. **Analysis of Options:** * **Alkaline Phosphatase (Correct):** It is the most sensitive marker for detecting osteoblastic skeletal metastases in prostate cancer patients. * **Acid Phosphatase (Incorrect):** Specifically, Prostatic Acid Phosphatase (PAP) was historically used to diagnose prostate cancer. However, it is a marker of the **primary tumor burden** and soft tissue extension rather than bone metastasis specifically. It has largely been replaced by PSA (Prostate-Specific Antigen) in modern practice. * **ESR (Incorrect):** While ESR may be elevated in chronic malignancies or inflammation, it is a non-specific marker and not a diagnostic biochemical indicator for metastatic prostate cancer. * **Bilirubin (Incorrect):** Bilirubin is a marker of hepatobiliary disease or hemolysis and is not typically elevated in prostate cancer unless there is extensive, rare liver metastasis. **High-Yield Clinical Pearls for NEET-PG:** 1. **PSA (Prostate-Specific Antigen):** The most sensitive and specific marker for screening, monitoring, and detecting recurrence of prostate cancer. 2. **Osteoblastic vs. Osteolytic:** Prostate cancer typically causes **osteoblastic** lesions (High ALP), whereas Multiple Myeloma causes **osteolytic** lesions (Normal ALP). 3. **Acid Phosphatase:** If the question asks for a marker that correlates with the *volume* of the primary tumor or extra-capsular spread, PAP is the traditional answer.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free